市場調査レポート：世界の非経口栄養薬市場（～2028年）：熱、アミノ酸、ビタミン

• 英文タイトル：Global Parenteral Nutrition Medicament Market Insights, Forecast to 2028

Global Parenteral Nutrition Medicament Market Insights, Forecast to 2028「世界の非経口栄養薬市場（～2028年）：熱、アミノ酸、ビタミン」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC2Q12-19316
• 出版社/出版日：QYResearch / 2022年12月
• レポート形態：英文、PDF、112ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：医薬品＆医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、非経口栄養薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
非経口栄養薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
非経口栄養薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
非経口栄養薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの非経口栄養薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の非経口栄養薬の売上および2028年までの予測に焦点を当てています。

非経口栄養薬のグローバル主要企業には、Baxter、B. Braun、Fresenius Kabi、Kelun Pharma、Otsuka Pharmaceutical、JW Pharmaceutical、Pfizer、Teva Pharmaceutical、Haisco Pharmaceutical Group、King York、Cisen、Lummy、Grand Life Sciences、Medisan、BBCA Pharmaceutical、Biokin Pharmaceutical、Xi'an Libang Pharmaceutical、Lionco Pharmaceutical、China Meheco Kangliなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

非経口栄養薬市場は、タイプとアプリケーションによって区分されます。世界の非経口栄養薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
熱、アミノ酸、ビタミン

【アプリケーション別セグメント】
最大100ml、250ml、500ml、最少1L

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 非経口栄養薬製品概要
- タイプ別市場（熱、アミノ酸、ビタミン）
- アプリケーション別市場（最大100ml、250ml、500ml、最少1L）
- 調査の目的
・エグゼクティブサマリー
- 世界の非経口栄養薬販売量予測2017-2028
- 世界の非経口栄養薬売上予測2017-2028
- 非経口栄養薬の地域別販売量
- 非経口栄養薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別非経口栄養薬販売量
- 主要メーカー別非経口栄養薬売上
- 主要メーカー別非経口栄養薬価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模（熱、アミノ酸、ビタミン）
- 非経口栄養薬のタイプ別販売量
- 非経口栄養薬のタイプ別売上
- 非経口栄養薬のタイプ別価格
・アプリケーション別市場規模（最大100ml、250ml、500ml、最少1L）
- 非経口栄養薬のアプリケーション別販売量
- 非経口栄養薬のアプリケーション別売上
- 非経口栄養薬のアプリケーション別価格
・北米市場
- 北米の非経口栄養薬市場規模（タイプ別、アプリケーション別）
- 主要国別の非経口栄養薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの非経口栄養薬市場規模（タイプ別、アプリケーション別）
- 主要国別の非経口栄養薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の非経口栄養薬市場規模（タイプ別、アプリケーション別）
- 主要国別の非経口栄養薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の非経口栄養薬市場規模（タイプ別、アプリケーション別）
- 主要国別の非経口栄養薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの非経口栄養薬市場規模（タイプ別、アプリケーション別）
- 主要国別の非経口栄養薬市場規模（トルコ、サウジアラビア）
・企業情報
Baxter、B. Braun、Fresenius Kabi、Kelun Pharma、Otsuka Pharmaceutical、JW Pharmaceutical、Pfizer、Teva Pharmaceutical、Haisco Pharmaceutical Group、King York、Cisen、Lummy、Grand Life Sciences、Medisan、BBCA Pharmaceutical、Biokin Pharmaceutical、Xi'an Libang Pharmaceutical、Lionco Pharmaceutical、China Meheco Kangli
・産業チェーン及び販売チャネル分析
- 非経口栄養薬の産業チェーン分析
- 非経口栄養薬の原材料
- 非経口栄養薬の生産プロセス
- 非経口栄養薬の販売及びマーケティング
- 非経口栄養薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 非経口栄養薬の産業動向
- 非経口栄養薬のマーケットドライバー
- 非経口栄養薬の課題
- 非経口栄養薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Parenteral Nutrition Medicament Market
Due to the COVID-19 pandemic, the global Parenteral Nutrition Medicament market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Heat accounting for % of the Parenteral Nutrition Medicament global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While max. 100ml segment is altered to an % CAGR throughout this forecast period.
China Parenteral Nutrition Medicament market size is valued at US$ million in 2021, while the US and Europe Parenteral Nutrition Medicament are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Parenteral Nutrition Medicament landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Parenteral Nutrition Medicament include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Parenteral Nutrition Medicament Scope and Segment
Parenteral Nutrition Medicament market is segmented by Type and by Packaging. Players, stakeholders, and other participants in the global Parenteral Nutrition Medicament market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Packaging for the period 2017-2028.
Segment by Type
Heat
Amino Acid
Vitamins
Segment by Packaging
max. 100ml
250ml
500ml
min. 1L
By Company
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Parenteral Nutrition Medicament Product Introduction
1.2 Market by Type
1.2.1 Global Parenteral Nutrition Medicament Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Heat
1.2.3 Amino Acid
1.2.4 Vitamins
1.3 Market by Packaging
1.3.1 Global Parenteral Nutrition Medicament Market Size Growth Rate by Packaging, 2017 VS 2021 VS 2028
1.3.2 max. 100ml
1.3.3 250ml
1.3.4 500ml
1.3.5 min. 1L
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parenteral Nutrition Medicament Sales Estimates and Forecasts 2017-2028
2.2 Global Parenteral Nutrition Medicament Revenue Estimates and Forecasts 2017-2028
2.3 Global Parenteral Nutrition Medicament Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Parenteral Nutrition Medicament Sales by Region
2.4.1 Global Parenteral Nutrition Medicament Sales by Region (2017-2022)
2.4.2 Global Sales Parenteral Nutrition Medicament by Region (2023-2028)
2.5 Global Parenteral Nutrition Medicament Revenue by Region
2.5.1 Global Parenteral Nutrition Medicament Revenue by Region (2017-2022)
2.5.2 Global Parenteral Nutrition Medicament Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Parenteral Nutrition Medicament Sales by Manufacturers
3.1.1 Global Top Parenteral Nutrition Medicament Manufacturers by Sales (2017-2022)
3.1.2 Global Parenteral Nutrition Medicament Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parenteral Nutrition Medicament in 2021
3.2 Global Parenteral Nutrition Medicament Revenue by Manufacturers
3.2.1 Global Parenteral Nutrition Medicament Revenue by Manufacturers (2017-2022)
3.2.2 Global Parenteral Nutrition Medicament Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Parenteral Nutrition Medicament Revenue in 2021
3.3 Global Parenteral Nutrition Medicament Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Parenteral Nutrition Medicament Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Parenteral Nutrition Medicament Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Parenteral Nutrition Medicament Sales by Type
4.1.1 Global Parenteral Nutrition Medicament Historical Sales by Type (2017-2022)
4.1.2 Global Parenteral Nutrition Medicament Forecasted Sales by Type (2023-2028)
4.1.3 Global Parenteral Nutrition Medicament Sales Market Share by Type (2017-2028)
4.2 Global Parenteral Nutrition Medicament Revenue by Type
4.2.1 Global Parenteral Nutrition Medicament Historical Revenue by Type (2017-2022)
4.2.2 Global Parenteral Nutrition Medicament Forecasted Revenue by Type (2023-2028)
4.2.3 Global Parenteral Nutrition Medicament Revenue Market Share by Type (2017-2028)
4.3 Global Parenteral Nutrition Medicament Price by Type
4.3.1 Global Parenteral Nutrition Medicament Price by Type (2017-2022)
4.3.2 Global Parenteral Nutrition Medicament Price Forecast by Type (2023-2028)
5 Market Size by Packaging
5.1 Global Parenteral Nutrition Medicament Sales by Packaging
5.1.1 Global Parenteral Nutrition Medicament Historical Sales by Packaging (2017-2022)
5.1.2 Global Parenteral Nutrition Medicament Forecasted Sales by Packaging (2023-2028)
5.1.3 Global Parenteral Nutrition Medicament Sales Market Share by Packaging (2017-2028)
5.2 Global Parenteral Nutrition Medicament Revenue by Packaging
5.2.1 Global Parenteral Nutrition Medicament Historical Revenue by Packaging (2017-2022)
5.2.2 Global Parenteral Nutrition Medicament Forecasted Revenue by Packaging (2023-2028)
5.2.3 Global Parenteral Nutrition Medicament Revenue Market Share by Packaging (2017-2028)
5.3 Global Parenteral Nutrition Medicament Price by Packaging
5.3.1 Global Parenteral Nutrition Medicament Price by Packaging (2017-2022)
5.3.2 Global Parenteral Nutrition Medicament Price Forecast by Packaging (2023-2028)
6 North America
6.1 North America Parenteral Nutrition Medicament Market Size by Type
6.1.1 North America Parenteral Nutrition Medicament Sales by Type (2017-2028)
6.1.2 North America Parenteral Nutrition Medicament Revenue by Type (2017-2028)
6.2 North America Parenteral Nutrition Medicament Market Size by Packaging
6.2.1 North America Parenteral Nutrition Medicament Sales by Packaging (2017-2028)
6.2.2 North America Parenteral Nutrition Medicament Revenue by Packaging (2017-2028)
6.3 North America Parenteral Nutrition Medicament Market Size by Country
6.3.1 North America Parenteral Nutrition Medicament Sales by Country (2017-2028)
6.3.2 North America Parenteral Nutrition Medicament Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Parenteral Nutrition Medicament Market Size by Type
7.1.1 Europe Parenteral Nutrition Medicament Sales by Type (2017-2028)
7.1.2 Europe Parenteral Nutrition Medicament Revenue by Type (2017-2028)
7.2 Europe Parenteral Nutrition Medicament Market Size by Packaging
7.2.1 Europe Parenteral Nutrition Medicament Sales by Packaging (2017-2028)
7.2.2 Europe Parenteral Nutrition Medicament Revenue by Packaging (2017-2028)
7.3 Europe Parenteral Nutrition Medicament Market Size by Country
7.3.1 Europe Parenteral Nutrition Medicament Sales by Country (2017-2028)
7.3.2 Europe Parenteral Nutrition Medicament Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Parenteral Nutrition Medicament Market Size by Type
8.1.1 Asia Pacific Parenteral Nutrition Medicament Sales by Type (2017-2028)
8.1.2 Asia Pacific Parenteral Nutrition Medicament Revenue by Type (2017-2028)
8.2 Asia Pacific Parenteral Nutrition Medicament Market Size by Packaging
8.2.1 Asia Pacific Parenteral Nutrition Medicament Sales by Packaging (2017-2028)
8.2.2 Asia Pacific Parenteral Nutrition Medicament Revenue by Packaging (2017-2028)
8.3 Asia Pacific Parenteral Nutrition Medicament Market Size by Region
8.3.1 Asia Pacific Parenteral Nutrition Medicament Sales by Region (2017-2028)
8.3.2 Asia Pacific Parenteral Nutrition Medicament Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Parenteral Nutrition Medicament Market Size by Type
9.1.1 Latin America Parenteral Nutrition Medicament Sales by Type (2017-2028)
9.1.2 Latin America Parenteral Nutrition Medicament Revenue by Type (2017-2028)
9.2 Latin America Parenteral Nutrition Medicament Market Size by Packaging
9.2.1 Latin America Parenteral Nutrition Medicament Sales by Packaging (2017-2028)
9.2.2 Latin America Parenteral Nutrition Medicament Revenue by Packaging (2017-2028)
9.3 Latin America Parenteral Nutrition Medicament Market Size by Country
9.3.1 Latin America Parenteral Nutrition Medicament Sales by Country (2017-2028)
9.3.2 Latin America Parenteral Nutrition Medicament Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Parenteral Nutrition Medicament Market Size by Type
10.1.1 Middle East and Africa Parenteral Nutrition Medicament Sales by Type (2017-2028)
10.1.2 Middle East and Africa Parenteral Nutrition Medicament Revenue by Type (2017-2028)
10.2 Middle East and Africa Parenteral Nutrition Medicament Market Size by Packaging
10.2.1 Middle East and Africa Parenteral Nutrition Medicament Sales by Packaging (2017-2028)
10.2.2 Middle East and Africa Parenteral Nutrition Medicament Revenue by Packaging (2017-2028)
10.3 Middle East and Africa Parenteral Nutrition Medicament Market Size by Country
10.3.1 Middle East and Africa Parenteral Nutrition Medicament Sales by Country (2017-2028)
10.3.2 Middle East and Africa Parenteral Nutrition Medicament Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 B. Braun
11.2.1 B. Braun Corporation Information
11.2.2 B. Braun Overview
11.2.3 B. Braun Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 B. Braun Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 B. Braun Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Kelun Pharma
11.4.1 Kelun Pharma Corporation Information
11.4.2 Kelun Pharma Overview
11.4.3 Kelun Pharma Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kelun Pharma Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kelun Pharma Recent Developments
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Corporation Information
11.5.2 Otsuka Pharmaceutical Overview
11.5.3 Otsuka Pharmaceutical Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Otsuka Pharmaceutical Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Otsuka Pharmaceutical Recent Developments
11.6 JW Pharmaceutical
11.6.1 JW Pharmaceutical Corporation Information
11.6.2 JW Pharmaceutical Overview
11.6.3 JW Pharmaceutical Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 JW Pharmaceutical Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 JW Pharmaceutical Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Overview
11.8.3 Teva Pharmaceutical Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceutical Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Recent Developments
11.9 Haisco Pharmaceutical Group
11.9.1 Haisco Pharmaceutical Group Corporation Information
11.9.2 Haisco Pharmaceutical Group Overview
11.9.3 Haisco Pharmaceutical Group Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Haisco Pharmaceutical Group Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Haisco Pharmaceutical Group Recent Developments
11.10 King York
11.10.1 King York Corporation Information
11.10.2 King York Overview
11.10.3 King York Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 King York Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 King York Recent Developments
11.11 Cisen
11.11.1 Cisen Corporation Information
11.11.2 Cisen Overview
11.11.3 Cisen Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Cisen Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cisen Recent Developments
11.12 Lummy
11.12.1 Lummy Corporation Information
11.12.2 Lummy Overview
11.12.3 Lummy Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Lummy Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Lummy Recent Developments
11.13 Grand Life Sciences
11.13.1 Grand Life Sciences Corporation Information
11.13.2 Grand Life Sciences Overview
11.13.3 Grand Life Sciences Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Grand Life Sciences Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Grand Life Sciences Recent Developments
11.14 Medisan
11.14.1 Medisan Corporation Information
11.14.2 Medisan Overview
11.14.3 Medisan Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Medisan Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Medisan Recent Developments
11.15 BBCA Pharmaceutical
11.15.1 BBCA Pharmaceutical Corporation Information
11.15.2 BBCA Pharmaceutical Overview
11.15.3 BBCA Pharmaceutical Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 BBCA Pharmaceutical Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 BBCA Pharmaceutical Recent Developments
11.16 Biokin Pharmaceutical
11.16.1 Biokin Pharmaceutical Corporation Information
11.16.2 Biokin Pharmaceutical Overview
11.16.3 Biokin Pharmaceutical Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Biokin Pharmaceutical Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Biokin Pharmaceutical Recent Developments
11.17 Xi’an Libang Pharmaceutical
11.17.1 Xi’an Libang Pharmaceutical Corporation Information
11.17.2 Xi’an Libang Pharmaceutical Overview
11.17.3 Xi’an Libang Pharmaceutical Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Xi’an Libang Pharmaceutical Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Xi’an Libang Pharmaceutical Recent Developments
11.18 Lionco Pharmaceutical
11.18.1 Lionco Pharmaceutical Corporation Information
11.18.2 Lionco Pharmaceutical Overview
11.18.3 Lionco Pharmaceutical Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Lionco Pharmaceutical Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Lionco Pharmaceutical Recent Developments
11.19 China Meheco Kangli
11.19.1 China Meheco Kangli Corporation Information
11.19.2 China Meheco Kangli Overview
11.19.3 China Meheco Kangli Parenteral Nutrition Medicament Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 China Meheco Kangli Parenteral Nutrition Medicament Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 China Meheco Kangli Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Parenteral Nutrition Medicament Industry Chain Analysis
12.2 Parenteral Nutrition Medicament Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Parenteral Nutrition Medicament Production Mode & Process
12.4 Parenteral Nutrition Medicament Sales and Marketing
12.4.1 Parenteral Nutrition Medicament Sales Channels
12.4.2 Parenteral Nutrition Medicament Distributors
12.5 Parenteral Nutrition Medicament Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Parenteral Nutrition Medicament Industry Trends
13.2 Parenteral Nutrition Medicament Market Drivers
13.3 Parenteral Nutrition Medicament Market Challenges
13.4 Parenteral Nutrition Medicament Market Restraints
14 Key Findings in The Global Parenteral Nutrition Medicament Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer